From the floor in Shenzhen: 12 posters, one theme
Reported from the sessions, and from the two hours afterwards.
Pricing
Page 11 of 25 of this archive, newest first.
Ireland declines to reimburse dulaglutide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
Italy declines to reimburse liraglutide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
Poland caps semaglutide prescribing to 20 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
Coming off: what the pharmacology permits
What a slow reduction could plausibly buy, and what it certainly cannot prevent.
The lead-in, the randomisation, and the year that followed
A withdrawal trial answers a narrower question than it appears to. This piece states which question.
From the floor in Shanghai: 7 posters, one theme
Reported from the sessions, and from the two hours afterwards.
The shortage years, and what they taught about interruption
Cost is the modal reason for discontinuation in every dataset we have seen, and it is absent from the clinical literature.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
From the floor in Xianning: 11 posters, one theme
Reported from the sessions, and from the two hours afterwards.
Sweden declines to reimburse exenatide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
The Netherlands declines to reimburse exenatide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
The shortage years, and what they taught about interruption
Real-world persistence figures, with their definitions stated, because the definitions are doing most of the work.
Sweden declines to reimburse liraglutide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
The United Kingdom caps liraglutide prescribing to 18 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
The withdrawal trials, read as designs rather than warnings
The evidence on stopping is better than the evidence on almost anything else in this field, because somebody deliberately randomised it.
From the floor in Chengdu: 13 posters, one theme
Reported from the sessions, and from the two hours afterwards.
The Netherlands caps dulaglutide prescribing to 8 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.